Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Clare Verrill and Dr Lisa Browning have been filmed demonstrating how to sample fresh tumours from prostate and renal cases for whole genome sequencing and the 100,000 Genomes Project.

Dr Clare Verrill demonstrating how to biobank prostate specimens

In interviews, Dr Verrill, who is a Senior Clinical Lecturer in Pathology at the Nuffield Department of Surgical Sciences and an Honorary Consultant in Cellular Pathology at Oxford University Hospitals NHS Foundation Trust, and Dr Browning (pictured below), who is an Honorary Senior Clinical Lecturer in Pathology at Oxford University and a Consultant Histopathologist, also discussed the benefits of sampling fresh tissue compared to formalin fixed samples.

Dr Lisa Browning demonstrating how to sample fresh tumours from renal cases.© NDSThe 100,000 Genomes Project aims to analyse whole genome sequences from thousands of patients to develop a greater understanding of the basis of disease. Around 1,200 samples from about 600 cancer patients and around 2,000 samples from about 660 rare disease patients will be collected.

It is vital that every patient who enrols on the cancer programme receives an accurate and timely report of the results of their whole genome sequencing. Every sample collected must deliver optimum insight and this will require changes to the way samples are handled.

Advances in genetic analysis and cheaper whole genome sequencing means sampling fresh tissue is now set to be standard cancer care. 

The videos will be hosted on the Genomics England website and disseminated across the NHS to support pathologists and other members of cancer multi-disciplinary teams with recruitment of patients on to the 100,000 Genomes Project and other similar genomics studies. They will also be shared with Health Education England and the Royal College of Pathologists for education and training.   

View all the videos featuring Dr Clare Verrill and Dr Lisa Browning here.

Similar stories

New Cochrane evidence explores treatment options for chronic ear disease

Publication Research

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.